RMB: 900 特惠 1500 1500
产品规格
Catalog# HA600098
xCT / SLC7A11 Mouse Monoclonal Antibody [A7C6]
-
WB
-
IF-Cell
-
IHC-P
-
FC
-
Human
-
Mouse
-
unconjugated
概述
产品名称
xCT / SLC7A11 Mouse Monoclonal Antibody [A7C6]
抗体类型
Mouse Monoclonal Antibody
免疫原
293 cell line overexpressing SLC7A11.
种属反应性
Human, Mouse
验证应用
WB, IF-Cell, IHC-P, FC
分子量
Predicted band size: 55 kDa
阳性对照
HT-29 cell lysates, HeLa, A549, HT-29, human colon tissue, human pancreas tissue.
偶联
unconjugated
克隆号
A7C6
RRID
产品特性
形态
Liquid
浓度
存放说明
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term.
存储缓冲液
PBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
亚型
IgG1
纯化方式
Protein A affinity purified.
应用稀释度
-
WB
-
1:1,000
-
IF-Cell
-
1:100-1:250
-
IHC-P
-
1:200-1:600
-
FC
-
1:1,000
靶点
功能
This gene encodes a member of a heteromeric, sodium-independent, anionic amino acid transport system that is highly specific for cysteine and glutamate. In this system, designated Xc(-), the anionic form of cysteine is transported in exchange for glutamate. This protein has been identified as the predominant mediator of Kaposi sarcoma-associated herpesvirus fusion and entry permissiveness into cells. Also, increased expression of this gene in primary gliomas (compared to normal brain tissue) was associated with increased glutamate secretion via the XCT channels, resulting in neuronal cell death.
背景文献
1. Koppula P. et. al. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021 Aug
2. Lin W. et. al. SLC7A11/xCT in cancer: biological functions and therapeutic implications. Am J Cancer Res. 2020 Oct
亚细胞定位
Cell membrane, Cell projection, microvillus membrane.
别名
Amino acid transport system xc xCT antibody antibody
Amino acid transport system xc- antibody
Calcium channel blocker resistance protein CCBR1 antibody
Calcium channel blocker resistance protein CCBR1 antibody antibody
CCBR1 antibody
Cysteine/glutamate transporter antibody antibody
Cystine/glutamate transporter antibody
OTTHUMP00000164578 antibody
SLC7A11 antibody
Solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 antibody
展开Amino acid transport system xc xCT antibody antibody
Amino acid transport system xc- antibody
Calcium channel blocker resistance protein CCBR1 antibody
Calcium channel blocker resistance protein CCBR1 antibody antibody
CCBR1 antibody
Cysteine/glutamate transporter antibody antibody
Cystine/glutamate transporter antibody
OTTHUMP00000164578 antibody
SLC7A11 antibody
Solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 antibody
solute carrier family 7 antibody
Solute carrier family 7 member 11 antibody
Solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 antibody
SYSTEM Xc(-) TRANSPORTER-RELATED PROTEIN antibody
xCT antibody
XCT_HUMAN antibody
折叠图片
-
Western blot analysis of xCT / SLC7A11 on HT-29 cell lysates with Mouse anti-xCT / SLC7A11 antibody (HA600098) at 1/1,000 dilution.
Lysates/proteins at 10 µg/Lane.
Predicted band size: 55 kDa
Observed band size: 55 kDa
Exposure time: 2 minute 30 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA600098) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Mouse IgG - HRP Secondary Antibody (HA1006) at 1/50,000 dilution was used for 1 hour at room temperature. -
Immunocytochemistry analysis of HeLa cells labeling xCT / SLC7A11 with Mouse anti-xCT / SLC7A11 antibody (HA600098) at 1/250 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Mouse anti-xCT / SLC7A11 antibody (HA600098) at 1/250 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
beta Tubulin (ET1602-4, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Rabbit IgG H&L (iFluor™ 594, HA1122) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of A549 cells labeling xCT / SLC7A11 with Mouse anti-xCT / SLC7A11 antibody (HA600098) at 1/250 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Mouse anti-xCT / SLC7A11 antibody (HA600098) at 1/250 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
beta Tubulin (ET1602-4, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Rabbit IgG H&L (iFluor™ 594, HA1122) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of HT-29 cells labeling xCT / SLC7A11 with Mouse anti-xCT / SLC7A11 antibody (HA600098) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Mouse anti-xCT / SLC7A11 antibody (HA600098) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
beta Tubulin (ET1602-4, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Rabbit IgG H&L (iFluor™ 594, HA1122) was used as the secondary antibody at 1/1,000 dilution. -
Flow cytometric analysis of HT-29 cells labeling xCT / SLC7A11.
Cells were washed twice with cold PBS and resuspend. Then stained with the primary antibody (HA600098, 1/1,000) (red) compared with Mouse IgG1 Isotype Control (green). After incubation of the primary antibody at +4℃ for 30 minutes, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Mouse IgG Secondary antibody (HA1125) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). -
Immunohistochemical analysis of paraffin-embedded human colon tissue with Mouse anti-xCT / SLC7A11 antibody (HA600098) at 1/600 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA600098) at 1/600 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human pancreas tissue with Mouse anti-xCT / SLC7A11 antibody (HA600098) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA600098) at 1/200 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
请注意: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
引文
-
Manganese Biomineralized Ferritin Nanoplatforms with Shielding and Stimuli-Responsive Release for Potentiated Ferroptosis and Multimodal Ovarian Cancer Therapy
期刊: International Journal Of Nanomedicine
DOI: 10.2147/IJN.S548411
IF: 6.5
应用: WB,IF
反应种属: Mouse,Human
发表时间: 2026 Jan
-
Synergistic ferroptosis-immunotherapy nanoassembly via PROTAC-mediated SLC7A11 degradation and trisulfide-driven glutathione depletion for enhanced antitumor efficacy
期刊: Chemical Engineering Journal
DOI: 10.1016/j.cej.2025.168827
IF: 13.2
应用: IF,WB
反应种属: Mouse
发表时间: 2025 Sept
-
Licochalcone B targets neural cell adhesion molecule 1 to inhibit osteosarcoma progression and ferroptosis resistance via extracellular signal-regulated kinase 5 and nuclear factor kappa B pathways
期刊: Phytomedicine
DOI: 10.1016/j.phymed.2025.157584
IF: 8.3
应用: WB
反应种属: Human
发表时间: 2025 Nov
-
Metformin exhibits inhibitory effects on ferroptosis and alleviates chondrocyte metabolic imbalance in osteoarthritis models, as well as Erastin-induced ferroptosis, through the modulation of the P53/SLC7A11 pathway
期刊: Biochemical Pharmacology
DOI: 10.1016/j.bcp.2025.116978
IF: 5.3
应用: WB/IF -Tissue
反应种属: Rat
发表时间: 2025 May
-
Iodine-131 induces ferroptosis and synergizes with sulfasalazine in differentiated thyroid cancer cells via suppressing SLC7A11
期刊: Frontiers In Oncology
DOI: 10.3389/fonc.2025.1580828
IF: 3.5
应用: WB
反应种属: Mouse,Human
发表时间: 2025 May
-
Vaccarin Ameliorates Renal Fibrosis by Inhibiting Ferroptosis via Nrf2/SLC7A11/GPX4 Signaling Pathway
期刊: Drug Design Development And Therapy
DOI: 10.2147/DDDT.S509357
IF: 4.7
应用: WB
反应种属: Mouse
发表时间: 2025 Mar
-
Inhalation exposure to cationic nanoplastic induces ferroptosis in the lung by perturbing core circadian transcription factors Bmal1
期刊: Journal Of Hazardous Materials
DOI: 10.1016/j.jhazmat.2025.139048
IF: 11.3
应用: WB
反应种属: Mouse
发表时间: 2025 Jun
-
5‐HT7R Deficiency Alleviates ADP‐Heptose‐Induced Cognitive Impairment via Inhibiting Ferroptosis and Neuroinflammation in Mice
期刊: CNS Neuroscience & Therapeutics
DOI: 10.1111/cns.70455
IF: 5
应用: WB
反应种属: Mouse
发表时间: 2025 Jun
-
3-hydroxyanthranilic acid analog mitigates ischemia-reperfusion injury by inhibiting cardiomyocyte ferroptosis through the activation of Nrf2/HO-1/GPX4
期刊: International Immunopharmacology
DOI: 10.1016/j.intimp.2025.115117
IF: 4.7
应用: WB
反应种属: Rat
发表时间: 2025 Jul
-
THEM6 modulates carboplatin sensitivity by regulating ferroptosis through FDFT1 in triple-negative breast cancer
期刊: Breast Cancer Research
DOI: 10.1186/s13058-025-02078-7
IF: 5.6
应用: WB
反应种属: Mouse,Human
发表时间: 2025 Jul
-
Synergizing Ferroptosis and Immunotherapy via a PROTAC/PDT/HPK1 Inhibitor-Loaded Nanoplatform for Enhanced Antitumor Efficacy
期刊: Advanced Functional Materials
DOI: 10.1002/adfm.202507906
IF: 19
应用: WB,IF
反应种属: Mouse
发表时间: 2025 Jul
-
WTX-L/β-arrestin2/LCN2 axis controls vulnerability to ferroptosis in gastric cancer
期刊: iScience
DOI: 10.1016/j.isci.2025.111964
IF: 4.6
应用: IF
反应种属: Human
发表时间: 2025 Feb
-
Almonertinib inhibits liver cancer progression by triggering autophagy-dependent ferroptosis through inhibition of the PI3K/Akt1/mTOR pathway
期刊: Biochemical Pharmacology
DOI: 10.1016/j.bcp.2025.117628
IF: 5.6
应用: WB
反应种属: Human
发表时间: 2025 Dec
-
F-box/WD Repeat-Containing Protein 5 Promotes Breast Cancer Progression by Regulating Ferroptosis via Enhancing Krüppel-like Factor 13 Ubiquitination Through Phosphoinositide 3-Kinase/Serine/Threonine Protein Kinase Pathway
期刊: Rejuvenation Research
DOI: 10.1089/rej.2024.0111
IF: 2.2
应用: WB
反应种属: Human
发表时间: 2025 Apr
-
Constitutive hepatic mTORC1 activation aggravates alcohol-induced liver injury via endoplasmic reticulum stress-mediated ferroptosis
期刊: American Journal Of Pathology
DOI: 10.1016/j.ajpath.2025.03.005
IF: 4.7
应用: WB
反应种属: Mouse
发表时间: 2025 Apr
-
Bioactive Nanoliposomes for Enhanced Sonodynamic-Triggered Disulfidptosis-Like Cancer Cell Death via Lipid Peroxidation
期刊: International Journal Of Nanomedicine
DOI: 10.2147/IJN.S464178
IF: 6.6
应用: IF
反应种属: Mouse
发表时间: 2024 Sept
-
QBT improved cognitive dysfunction in rats with vascular dementia by regulating the Nrf2/xCT/GPX4 and NLRP3/Caspase-1/GSDMD pathways to inhibit ferroptosis and pyroptosis of neurons
期刊: International Immunopharmacology
DOI:
IF: 4.8
应用: WB
反应种属: Rat
发表时间: 2024 Sep
-
Polystyrene nanoplastic exposure actives ferroptosis by oxidative stress-induced lipid peroxidation in porcine oocytes during maturation
期刊: Journal Of Animal Science And Biotechnology
DOI:
IF: 6.3
应用: WB
反应种属: Pig
发表时间: 2024 Sep
-
The SIRT6/BAP1/xCT signaling axis mediates ferroptosis in cisplatin-induced AKI
期刊: Cellular Signalling
DOI:
IF: 4.4
应用: WB
反应种属: Human
发表时间: 2024 Oct
-
Shikonin induces ferroptosis in osteosarcomas through the mitochondrial ROS-regulated HIF-1α/HO-1 axis
期刊: Phytomedicine
DOI:
IF: 6.7
应用: IHC-P
反应种属: Mouse
发表时间: 2024 Oct
-
NPR1 promotes cisplatin resistance by inhibiting PARL-mediated mitophagy-dependent ferroptosis in gastric cancer
期刊: Cell Biology And Toxicology
DOI:
IF: 5.3
应用: WB
反应种属: Mouse
发表时间: 2024 Nov
-
Nicotine promotes Staphylococcus aureus-induced osteomyelitis by activating the Nrf2/Slc7a11 signaling axis
期刊: International Immunopharmacology
DOI:
IF: 5.6
应用: IHC-P,IF
反应种属: Mouse
发表时间: 2024 May
-
Sensing of mitochondrial DNA by ZBP1 promotes RIPK3- mediated necroptosis and ferroptosis in response to diquat poisoning
期刊: Cell Death & Differentiation
DOI:
IF: 13.7
应用: WB
反应种属: Mouse
发表时间: 2024 May
-
Saikosaponin A attenuates osteoclastogenesis and bone loss by inducing ferroptosis
期刊: Frontiers In Molecular Biosciences
DOI: 10.3389/fmolb.2024.1390257
IF: 3.9
应用: WB
反应种属: Mouse
发表时间: 2024 Jul
-
Site 1 protease aggravates acute kidney injury by promoting tubular epithelial cell ferroptosis through SIRT3-SOD2-mtROS signaling
期刊: FEBS Journal
DOI: 10.1111/febs.17057
IF: 5.5
应用: WB
反应种属: Mouse
发表时间: 2024 Jan
-
Tomatidine Alleviates Intervertebral Disc Degeneration by Activating the Nrf2/HO-1/GPX4 Signaling Pathway
期刊: Drug Design Development And Therapy
DOI:
IF: 4.7
应用: WB
反应种属: Rat
发表时间: 2024 Dec
-
FBXW7-Mediated Downregulation of GPX4 Aggravates Acute Kidney Injury Following Ischemia‒Reperfusion
期刊: Inflammation
DOI: 10.1007/s10753-024-02137-9
IF: 4.5
应用: WB
反应种属: Human
发表时间: 2024 Aug
-
MAPK Signaling-Mediated RFNG Phosphorylation and Nuclear Translocation Restrain Oxaliplatin-Induced Apoptosis and Ferroptosis
期刊: Advanced Science
DOI:
IF: 14.3
应用: IHC-P
反应种属: Human
发表时间: 2024 Aug
-
Multimodal enhancement of ferroptosis for synergistic cascade colorectal cancer therapy
期刊: Chemical Engineering Journal
DOI:
IF: 13.3
应用: WB
反应种属: Mouse
发表时间: 2024 Aug
-
Hsa-miR-26a-5p improves OSCC sensitivity to ferroptosis by inhibiting SLC7A11
期刊: Archives Of Oral Biology
DOI: 10.1016/j.archoralbio.2023.105807
IF: 3
应用: IHC-P
反应种属: Human
发表时间: 2023 Sept
-
YAP/ACSL4 Pathway-Mediated Ferroptosis Promotes Renal Fibrosis in the Presence of Kidney Stones
期刊: Biomedicines
DOI:
IF: 4.7
应用: WB
反应种属: Mouse
发表时间: 2023 Oct
-
Interleukin-17 alleviates erastin-induced alveolar bone loss by suppressing ferroptosis via interaction between NRF2 and p-STAT3
期刊: Journal Of Clinical Periodontology
DOI:
IF: 6.7
应用: IHC-P
反应种属: Mouse
发表时间: 2023 Nov
-
Anomanolide C suppresses tumor progression and metastasis by ubiquitinating GPX4-driven autophagy-dependent ferroptosis in triple negative breast cancer
期刊: International Journal Of Biological Sciences
DOI:
IF: 10.750
应用: WB
反应种属: Mouse
发表时间: 2023 May
-
H1N1 influenza virus infection through NRF2-KEAP1-GCLC pathway induces ferroptosis in nasal mucosal epithelial cells
期刊: Free Radical Biology And Medicine
DOI:
IF: 7.4
应用: WB
反应种属: Mouse
发表时间: 2023 Aug
-
p53 deacetylation alleviates calcium oxalate deposition-induced renal fibrosis by inhibiting ferroptosis
期刊: Biomedicine & Pharmacotherapy
DOI:
IF: 7.5
应用: WB
反应种属: Mouse
发表时间: 2023 Aug
同靶点 & 同通路的产品
xCT / SLC7A11 Recombinant Mouse Monoclonal Antibody [A7C6-R]
Application: WB,IHC-P,IF-Cell,FC
Reactivity: Human,Mouse
Conjugate: unconjugated
xCT / SLC7A11 Recombinant Mouse Monoclonal Antibody [A7C6-R] - BSA and Azide free
Application: WB,IHC-P,IF-Cell,FC
Reactivity: Human,Mouse
Conjugate: unconjugated
xCT / SLC7A11 Mouse Monoclonal Antibody [A7C5]
Application: WB,IHC-P,FC
Reactivity: Human,Mouse
Conjugate: unconjugated
xCT / SLC7A11 Recombinant Rabbit Monoclonal Antibody [JE31-93]
Application: WB,IP
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated

浙公网安备 33019202000643号